Why does hemoconcentration decrease after a blood transfusion in patients with end-stage renal disease (ESRD) undergoing hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Hemoconcentration Decreases After Blood Transfusion in Hemodialysis Patients

Direct Answer

Blood transfusion in hemodialysis patients decreases hemoconcentration because the transfused packed red blood cells increase intravascular volume and red cell mass, which improves hemodynamic stability and reduces the rate of ultrafiltration-induced volume contraction that normally occurs during dialysis. 1

Physiological Mechanism

Hemodynamic Stabilization

  • Transfusion raises intradialytic blood pressure and slows the rate of mean arterial pressure decline during dialysis, preventing the compensatory hemoconcentration that occurs when patients become hypovolemic 1
  • In a study of 25 ESRD patients with severe anemia (mean hemoglobin 5.9 g/dL), transfusion of 2 units of packed red cells reduced hypotensive episodes from 28 to 12 episodes (p=0.02) 1
  • The improved hemodynamic stability means less need for compensatory fluid shifts from extravascular to intravascular compartments, which normally cause hemoconcentration 1

Volume Distribution Changes

  • Hemoglobin concentration depends on both red cell mass AND plasma volume—transfusion increases red cell mass while simultaneously affecting plasma volume distribution 2
  • The infusion of packed red blood cells (approximately 200-300 mL per unit) expands intravascular volume, which dilutes the blood and reduces hemoconcentration 2
  • Mean postdialysis weight fell from 62.0 kg before transfusion to 61.5 kg following transfusion (p<0.001), indicating better volume control without excessive hemoconcentration 1

Reduced Ultrafiltration Stress

  • Transfusion reduces the need for aggressive ultrafiltration by improving oxygen-carrying capacity, allowing more gradual fluid removal without triggering compensatory hemoconcentration 1
  • Intravenous sodium chloride used to treat hypotension declined from 20.4 to 10.2 mEq per dialysis (p=0.01) after transfusion, indicating less hemodynamic instability and less need for volume expansion that would cause hemoconcentration 1

Clinical Context in Hemodialysis

Normal Hemoconcentration During Dialysis

  • During standard hemodialysis, ultrafiltration removes plasma water faster than it can be mobilized from extravascular spaces, causing transient hemoconcentration 2
  • This hemoconcentration is a normal compensatory response to volume removal but becomes problematic in severely anemic patients who cannot tolerate the hemodynamic stress 1

Post-Transfusion Changes

  • After transfusion, the improved red cell mass and oxygen delivery capacity allows patients to tolerate ultrafiltration without excessive sympathetic activation and fluid shifts 1
  • The reduction in hypotensive episodes (from 28 to 12) demonstrates that transfusion stabilizes the cardiovascular response to volume removal 1

Important Clinical Pitfalls

Avoid Confusing Hemodilution with Decreased Hemoconcentration

  • The saline reinfused at the end of hemodialysis (150-500 mL) can dilute plasma and lower hemoglobin concentration, but this is a measurement artifact, not the primary mechanism of reduced hemoconcentration 2
  • For small patients with diminished intravascular distribution volume, this saline dilution effect can be noteworthy and should not be confused with the physiologic changes from transfusion 2

Transfusion Timing Considerations

  • In hemodialysis patients with hemoglobin <6 g/dL, transfusion should be immediate to prevent the severe hemodynamic instability that leads to excessive hemoconcentration during ultrafiltration 3
  • Each unit of packed red blood cells increases hemoglobin by approximately 1-1.5 g/dL, but the hemodynamic benefits occur before the full hematocrit rise is apparent 3

Monitoring Requirements

  • Blood losses in hemodialysis patients average 165 mL/year from the dialysis technique itself, but can reach 2,680 mL/year with double-lumen catheters, contributing to chronic anemia and abnormal hemoconcentration patterns 2
  • Regular monitoring of hemoglobin is essential because hemoconcentration during dialysis may mask the true severity of anemia 2

References

Research

The effect of red cell transfusion on hemodialysis-related hypotension.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1988

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Blood Transfusion Guidelines for Severe Anemia in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management plan for a 48-year-old female with impaired renal function (eGFR 65)?
What is erythema infectiosum (Fifth disease)?
What is the best treatment approach for a 65-year-old male with End-Stage Renal Disease (ESRD) on dialysis and a Gleason score 8 prostate cancer with no evidence of metastasis?
What home health interventions are appropriate for a 74-year-old female with hypertension, hyperlipidemia, end-stage renal disease (ESRD) on dialysis, anxiety disorder, insomnia, gastroesophageal reflux disease (GERD), generalized muscle weakness, and urinary incontinence, taking medications including quetiapine (Seroquel) 25mg, alprazolam 0.5mg, cetirizine (Zyrtec) 10mg, amlodipine 10mg, esomeprazole (Nexium) 40mg, labetalol 200mg, losartan 100mg, furosemide 40mg, zolpidem 12.5mg, sevelamer 800mg, and albuterol sulfate, with normal vitals and hypotension, and an allergy to codeine?
What is the most appropriate next step in managing a 32-year-old woman with Systemic Lupus Erythematosus (SLE) and newly diagnosed Hypertension (high blood pressure) and Nephrotic Syndrome (characterized by severe proteinuria), currently treated with Prednisone (corticosteroid)?
Is packing recommended for a large superficial shoulder abscess?
Can a patient with symptomatic amoebiasis and fecal analysis showing both Entamoeba histolytica and Entamoeba dispar cysts use metronidazole for treatment?
What is the recommended dose of acyclovir (antiviral medication) for an adult patient with a history of genital herpes for suppressive therapy?
Is there a drug interaction between collagen and Abraxane (paclitaxel) in a patient undergoing chemotherapy?
What is the recommended oral dose of trimethoprim (TMP) sulfamethoxazole (SMX) for an adult patient with a serious urinary tract infection (UTI) and presumed normal renal function?
Is there a drug interaction between valerian and Abraxane (paclitaxel) in an adult cancer patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.